Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,650Revenue $M893Net Margin (%)-5.6Altman Z-Score2.9
Enterprise Value $M1,984EPS $-1.0Operating Margin %-3.0Piotroski F-Score5
P/E(ttm)65.8Beneish M-Score-2.8Pre-tax Margin (%)-4.0Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %3.0Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %-2.2Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow98.3y-y EBITDA Growth Rate %14.2ROA % (ttm)-3.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-6.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M50.7ROIC % (ttm)-4.3Gross Margin Increase y-yN

Gurus Latest Trades with HAE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEJames Barrow 2015-12-31 Reduce-0.02%$30.85 - $34.37
($32.41)
$ 32.450%Reduce -17.64%1,844,774
HAEKen Fisher 2015-12-31 Add$30.85 - $34.37
($32.43)
$ 32.450%Add 4.88%219,110
HAEJames Barrow 2015-09-30 Reduce-0.01%$32.32 - $41.05
($37.68)
$ 32.45-14%Reduce -4.12%2,239,841
HAEJoel Greenblatt 2015-09-30 Sold Out -0.01%$32.32 - $41.05
($37.68)
$ 32.45-14%Sold Out0
HAEKen Fisher 2015-09-30 Add$32.32 - $41.05
($37.68)
$ 32.45-14%Add 10.24%208,920
HAEJoel Greenblatt 2015-06-30 Add0.01%$40.11 - $44.93
($42.2)
$ 32.45-23%Add 369.65%35,271
HAEKen Fisher 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 32.45-23%Reduce -2.43%189,520
HAEJames Barrow 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 32.45-23%Reduce -0.42%2,336,063
HAEJoel Greenblatt 2015-03-31 Buy $36.92 - $45.38
($41.8)
$ 32.45-22%New holding7,510
HAEJames Barrow 2015-03-31 Reduce$36.92 - $45.38
($41.8)
$ 32.45-22%Reduce -0.12%2,345,971
HAEJoel Greenblatt 2014-12-31 Sold Out -0.01%$34.15 - $38.88
($36.69)
$ 32.45-12%Sold Out0
HAEJoel Greenblatt 2014-09-30 Reduce$34.1 - $37.1
($35.69)
$ 32.45-9%Reduce -23.47%29,531
HAERobert Olstein 2014-06-30 Sold Out -0.06%$30.36 - $35.62
($33.37)
$ 32.45-3%Sold Out0
HAEKen Fisher 2014-06-30 Add$30.36 - $35.62
($33.37)
$ 32.45-3%Add 20.48%177,645
HAEFirst Eagle Investment 2014-06-30 Sold Out $30.36 - $35.62
($33.37)
$ 32.45-3%Sold Out0
HAEJames Barrow 2014-03-31 Add0.1%$31.84 - $43.37
($38.44)
$ 32.45-16%Add 217.54%3,042,669
HAERobert Olstein 2014-03-31 Buy 0.06%$31.84 - $43.37
($38.44)
$ 32.45-16%New holding14,400
HAEJoel Greenblatt 2014-03-31 Buy 0.02%$31.84 - $43.37
($38.44)
$ 32.45-16%New holding42,809
HAEJames Barrow 2013-12-31 Buy 0.06%$38.87 - $43.83
($41.15)
$ 32.45-21%New holding958,209
HAEThird Avenue Management 2013-12-31 Sold Out -0.03%$38.87 - $43.83
($41.15)
$ 32.45-21%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Selman ByronPresident, Global Markets 2015-10-26Sell344$32.131view
White JonathanChief Science and Technology 2015-10-26Sell319$32.131view
Jesse SandraEVP and Chief Legal Officer 2015-10-26Sell778$32.131view
HANLON SUSAN MVP Finance 2015-10-26Sell497$32.131view
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-10-26Sell436$32.131view
Davies Kent JCOO 2015-10-23Sell278$31.752.2view
Selman ByronPresident, Global Markets 2015-10-23Sell191$31.752.2view
Jesse SandraEVP and Chief Legal Officer 2015-10-23Sell250$31.752.2view
White JonathanChief Science and Technology 2015-10-23Sell250$31.752.2view
HANLON SUSAN MVP Finance 2015-10-23Sell162$31.752.2view

Quarterly/Annual Reports about HAE:

News about HAE:

Articles On GuruFocus.com
DENTSPLY´s Growth Opportunities Dec 16 2014 
Meridian Contrarian Fund Second Quarter Commentary Sep 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
This Blood Management Company Can Be A Safe Investment Jul 13 2014 
Meridian Funds Comments on Haemonetics Aug 28 2013 
Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD Jan 21 2013 

More From Other Websites
HAEMONETICS CORP Financials Feb 06 2016
Haemonetics Corp. Earnings Analysis: Q3, 2016 By the Numbers Feb 03 2016
HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report Feb 02 2016
Haemonetics Tops Q3 Earnings, Lags Revenues; Keeps View Feb 02 2016
Edited Transcript of HAE earnings conference call or presentation 1-Feb-16 1:00pm GMT Feb 01 2016
Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : February 1, 2016 Feb 01 2016
Haemonetics Corp Earnings Call scheduled for 8:00 am ET today Feb 01 2016
Q3 2016 Haemonetics Corp Earnings Release - Before Market Open Feb 01 2016
Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue... Feb 01 2016
HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 01 2016
Haemonetics reports 3Q loss Feb 01 2016
Haemonetics reports 3Q loss Feb 01 2016
Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue... Feb 01 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 19 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 11 2016
Haemonetics Sets Date for 3rd Quarter Fiscal 2016 Earnings Release: February 1, 2016 Jan 07 2016
Haemonetics Sets Date for 3rd Quarter Fiscal 2016 Earnings Release: February 1, 2016 Jan 07 2016
Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : December 29, 2015 Dec 29 2015
Haemonetics Hit by Russia Weakness, Choppy FY16 View Dec 07 2015
Cerus Announces Collaboration Agreement With Haemonetics for the Use of Acrodose Platelet Kits With... Dec 02 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK